Gliosarcoma

Caring for someone with this diagnosis? Eleplan keeps diagnoses, medications, documents and every specialist in one plan.

Start free with Eleplan

Gliosarcoma

ORPHA:251576Histopathological subtype

What it is

Orphanet has not published a description for this disease yet. The identifiers, classification and cross-references below are still current.

Key facts

Prevalence
<1 / 1 000 000 (annual incidence, Europe)
Age of onset
Adult
Inheritance
Not applicable
Classified as
Histopathological subtype

Prevalence figures describe populations, not individuals, and are often estimates from a single study. Where the figure is an incidence or a birth prevalence, it says so.

Genes

LZTR1Disease-causing somatic mutation(s)
EGFRPart of a fusion gene
FGFR1Part of a fusion gene
FGFR3Part of a fusion gene
IDH1Biomarker tested
MGMTBiomarker tested
NFKBIABiomarker tested
PPARGBiomarker tested
SEPTIN14Part of a fusion gene
TACC1Part of a fusion gene
TACC3Part of a fusion gene
TP53Biomarker tested

ICD-10 codes

C71.9filed under a broader ICD-10 category — shared with 26 other rare diseases

ICD-10 has no distinct code for most rare diseases, so many are filed under the nearest available one. A shared code identifies the group, not this disease — the ORPHAcode above is what identifies it.

Related health topics

Reached through the ICD-10 categories this disease is filed under, so these describe the broader group rather than this disease specifically.

Cross-references

GARD 5653MEDDRA 10018340MESH D018316MONDO 0016681UMLS C0206726

Orphadata Science: Free access data from Orphanet. © INSERM 1999. Data version 2026-06-23. Available under CC BY 4.0. This is a reference, not medical advice.

Powered by Eleplan

A rare diagnosis is just the start. Eleplan keeps the whole care plan in one place.

Diagnoses, medications, documents, appointments, and the whole care team — organized and always in sync, so you are not retelling the same story to every new specialist. With Ellie, your AI care assistant, on top of it. Free to start.